Dr Lee C Hang-fu, MD | |
21080 Lorain Rd, Fairview Park, OH 44126-2127 | |
(440) 333-9801 | |
(440) 333-4669 |
Full Name | Dr Lee C Hang-fu |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 21080 Lorain Rd, Fairview Park, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548286727 | NPI | - | NPPES |
0846679 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 35-061505 (Ohio) | Primary |
208200000X | Plastic Surgery | 4301049252 (Michigan) | Secondary |
208200000X | Plastic Surgery | 25MA05329900 (New Jersey) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Lee C Hang-fu, MD 21080 Lorain Rd, Fairview Park, OH 44126-2127 Ph: (440) 333-9801 | Dr Lee C Hang-fu, MD 21080 Lorain Rd, Fairview Park, OH 44126-2127 Ph: (440) 333-9801 |
News Archive
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
A first-of-its-kind clinical trial involving more than 600 children in Kenya and Tanzania, in which community members were trained to deliver mental health treatment, showed improvement in participants' trauma-related symptoms up to a year after receiving therapy, new research shows.
TEXO Ventures, a venture capital firm focused on building innovative healthcare companies through seed and early stage investment, announced the official launch of their new investment approach.
10x Genomics, a company focused on improving and broadening the application of genomic information across healthcare and other industries, today announced the publication of a study that was enabled by the company's GemCode™ technology platform, a powerful new approach that allows researchers to discover previously inaccessible genomic information.
University of Tübingen and Mediso Ltd announced today at the 4th Tübingen PET/MR Workshop to enter into a collaboration to develop a whole body preclinical PET insert based on silicon photomultiplier sensor technology. This system can be inserted into a high field (7T) preclinical MRI scanner to enable simultaneous PET/MR imaging.
› Verified 5 days ago